Genetics of Blood Disorders
A special issue of Genes (ISSN 2073-4425). This special issue belongs to the section "Molecular Genetics and Genomics".
Deadline for manuscript submissions: closed (20 August 2023) | Viewed by 21767
Special Issue Editor
Interests: prognostic factors in leukemia and lymphoma; methods of molecular diagnostics in blood diseases; molecular monitoring of therapy efficacy (including transplantation)
Special Issue Information
Dear Colleagues,
The study of the genetic basis of blood disorders has been at the forefront of medical genetics since the work of Alexander Maksimov in 1909, who postulated the clonal nature of hematopoiesis. The hematopoietic system is a unique object for the study of both germinal factors leading to various hereditary diseases and somatic mutations associated with malignancies. Advances in genetics and molecular biology in recent years have made it possible to significantly clarify understanding of the pathogenesis of hematological diseases. In connection with the development of targeted therapy approaches, the study of the molecular basis of blood diseases and the search for and characterization of appropriate genetic targets for therapeutic intervention are becoming increasingly important.
We encourage the submission of original manuscripts containing new, unpublished data relating to a wide range of genetic studies in hematology. Manuscripts on molecular genetic studies of hereditary blood diseases, neoplasia of lymphoid and myeloid tissue, genetic factors associated with the prognosis of disease or the effectiveness of therapy, etc., are invited. The intended publication formats to be considered include original articles, short communications, and literature reviews.
Dr. Andrey Sudarikov
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Genes is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- hereditary blood disorders
- leukemia
- lymphoma
- myeloproliferative neoplasms
- somatic mutations in clonal hematopoiesis
- molecular targets for therapy